Long Term Treatment with Idebenone in Leber's Hereditary Optic Neuropathy (LHON): Real World Clinical Practice

Update Item Information
Identifier 20180306_nanos_posters_152
Title Long Term Treatment with Idebenone in Leber's Hereditary Optic Neuropathy (LHON): Real World Clinical Practice
Creator Xavier Llòria, Claudia Catarino, Magda Silva, Bettina von Livonius, Constanze Gallenmüller, Felice Lob, Günther Rudolph, Oskars Mikazans, Thomas Klopstock
Subject Optic Neuropathy
Description LHON is caused by mitochondrial DNA (mtDNA) mutations, resulting in progressive bilateral, severe central blindness. Idebenone (900 mg/day) is approved for use in LHON in the EU . We report long-term treatment outcomes in real-world clinical practice from a multicenter Expanded Access Program.
Date 2018-03
Language eng
Format application/pdf
Source 2018 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS 2018: Poster Presentations
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Rights Management Copyright 2018. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s62z55rm
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Contributor Primary Xavier Llòria
Contributor Secondary Claudia Catarino, Magda Silva, Bettina von Livonius, Constanze Gallenmüller, Felice Lob, Günther Rudolph,; Oskars Mikazans, Thomas Klopstock
Setname ehsl_novel_nam
ID 1309574
Reference URL https://collections.lib.utah.edu/ark:/87278/s62z55rm
Back to Search Results